Oncoplastic Breast Reduction: A Systematic Review of Postoperative Complications.

Autor:	Benedict KC; From the Division of Plastic and Reconstructive Surgery, University of Mississippi Medical Center, Jackson, Miss., Brown MI; School of Medicine, University of Mississippi Medical Center, Jackson, Miss., Berry HA; School of Medicine, University of Mississippi Medical Center, Jackson, Miss., Berry SM; Department of Surgery, University of Mississippi Medical Center, Jackson, Miss., O'Brien RC; Department of Data Science, University of Mississippi Medical Center, Jackson, Miss., Davis JM; From the Division of Plastic and Reconstructive Surgery, University of Mississippi Medical Center, Jackson, Miss.
Jazyk:	angličtina
Zdroj:	Plastic and reconstructive surgery. Global open [Plast Reconstr Surg Glob Open] 2023 Oct 16; Vol. 11 (10), pp. e5355. Date of Electronic Publication: 2023 Oct 16 (Print Publication: 2023).
DOI:	10.1097/GOX.0000000000005355
Abstrakt:	Background: Breast-conserving therapy with oncoplastic reduction is a useful strategy for partial mastectomy defect reconstruction. The most recently published systematic review of oncoplastic breast reduction outcomes from 2015 showed wound dehiscence in 4.3%, hematoma in 0.9%, infection in 2.8%, and nipple necrosis in 0.9% of patients. We performed a systematic review of oncoplastic breast reduction literature, comparing outcomes and complication rates reported over the past 8 years. Methods: Studies describing the use of oncoplastic breast reduction and discussion of postoperative complications were included. The primary outcome assessed was the postoperative complication rate; secondary outcomes analyzed were rates of margin expansion, completion mastectomy, and delays in adjuvant therapy due to complications. Results: Nine articles met inclusion criteria, resulting in 1715 oncoplastic breast reduction patients. The mean rate of hematoma was 3%, nipple necrosis was 2%, dehiscence was 4%, infection was 3%, and seroma was 2%. The need for re-excision of margins occurred in 8% of patients, and completion mastectomy in 2%. Finally, delay in adjuvant treatment due to a postoperative complication occurred in 4% of patients. Conclusions: Oncoplastic breast reduction is an excellent option for many patients undergoing breast-conserving therapy; however, postoperative complications can delay adjuvant radiation therapy. Results of this systematic literature review over the past 8 years showed a slight increase in complication rate compared to the most recent systematic review from 2015. With increased popularity and surgeon familiarity, oncoplastic breast reduction remains a viable option for reconstruction of partial mastectomy defects despite a slight increase in complication rate. Competing Interests: The authors have no financial interest to declare in relation to the content of this article. Disclosure statements are at the end of this article, following the correspondence information. (Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu